Literature DB >> 34038223

Natural antioxidants attenuate mycolactone toxicity to RAW 264.7 macrophages.

Yvonne A Kwaffo1,2, Mabel Sarpong-Duah2, Kwabena Owusu-Boateng1,2, Winfred Sk Gbewonyo2, Jonathan P Adjimani2, Lydia Mosi1,2.   

Abstract

Mycobacterium ulcerans produces a macrolide exotoxin, mycolactone which suppresses immune cells activity, is toxic to most cells and the key virulence factor in the pathogenesis of Buruli ulcer disease. Mycolactone is reported to mediate the production of reactive oxygen species in keratinocytes; cells that play critical role in wound healing. Increased levels of reactive oxygen species have been shown to disrupt the well-ordered process of wound repair; hence, the function of wound-healing cells such as macrophages, keratinocytes, and fibroblast could be impaired in the presence of the reactive oxygen species mediator, mycolactone. To ensure regeneration of tissues in chronic ulcers, with proper and timely healing of the wounds, natural antioxidants that can combat the effects of induced reactive oxygen species in wound-healing cells ought to be investigated. Reactive oxygen species activity was determined in mycolactone-treated RAW 264.7 macrophages and the scavenging ability of the antioxidants (ascorbic acid, gallic acid, and green tea kombucha) against mycolactone-induced reactive oxygen species (superoxide anions) was assessed using fluorescein probe (DCF-DA) and nitroblue tetrazolium dye. Cytotoxicity of the antioxidants, mycolactone, and the protective effect of the antioxidants on the cells upon treatment with mycolactone were determined using the Alamar blue assay. The expression levels of endogenous antioxidant enzyme genes (superoxide dismutase, catalase, and glutathione peroxidase) in response to mycolactone-mediated reactive oxygen species were determined using RT-qPCR. Mycolactone induced the production of reactive oxygen species in RAW 264.7 macrophages, and the resulting superoxide anions were scavenged by some of the antioxidants. The selected endogenous antioxidant enzyme genes in the macrophages were upregulated in the presence of the antioxidants and mycolactone. The exogenously supplied ascorbic acid and green tea kombucha offered moderate protection to the macrophages against the toxicity of mycolactone. We conclude that the results provide insights into alternate and adjunct therapeutic approaches in Buruli ulcer treatment, which could significantly attenuate the toxicity of the pathogenic factor; mycolactone.

Entities:  

Keywords:  Buruli ulcer; antioxidants; cytotoxicity; kombucha; macrophage; mycolactone

Mesh:

Substances:

Year:  2021        PMID: 34038223      PMCID: PMC8424639          DOI: 10.1177/15353702211015628

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  28 in total

Review 1.  Extracellular matrix metabolites as potential biomarkers of disease activity in wound fluid: lessons learned from other inflammatory diseases?

Authors:  R Moseley; J E Stewart; P Stephens; R J Waddington; D W Thomas
Journal:  Br J Dermatol       Date:  2004-03       Impact factor: 9.302

2.  Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence.

Authors:  K M George; D Chatterjee; G Gunawardana; D Welty; J Hayman; R Lee; P L Small
Journal:  Science       Date:  1999-02-05       Impact factor: 47.728

Review 3.  Macrophages in Tissue Repair, Regeneration, and Fibrosis.

Authors:  Thomas A Wynn; Kevin M Vannella
Journal:  Immunity       Date:  2016-03-15       Impact factor: 31.745

4.  Mycobacterium ulcerans toxic macrolide, mycolactone modulates the host immune response and cellular location of M. ulcerans in vitro and in vivo.

Authors:  Sarojini Adusumilli; Armand Mve-Obiang; Tim Sparer; Wayne Meyers; John Hayman; Pamela Long Claus Small
Journal:  Cell Microbiol       Date:  2005-09       Impact factor: 3.715

5.  Mycobacterium ulcerans cytotoxicity in an adipose cell model.

Authors:  K M Dobos; P L Small; M Deslauriers; F D Quinn; C H King
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

6.  Protective activity of hamamelitannin on cell damage of murine skin fibroblasts induced by UVB irradiation.

Authors:  H Masaki; T Atsumi; H Sakurai
Journal:  J Dermatol Sci       Date:  1995-07       Impact factor: 4.563

7.  Clinical efficacy of combination of rifampin and streptomycin for treatment of Mycobacterium ulcerans disease.

Authors:  Fred Stephen Sarfo; Richard Phillips; Kingsley Asiedu; Edwin Ampadu; Nana Bobi; E Adentwe; Awuli Lartey; Ishmael Tetteh; M Wansbrough-Jones
Journal:  Antimicrob Agents Chemother       Date:  2010-06-21       Impact factor: 5.191

8.  Hydrogen peroxide protects tobacco from oxidative stress by inducing a set of antioxidant enzymes.

Authors:  T Gechev; I Gadjev; F Van Breusegem; D Inzé; S Dukiandjiev; V Toneva; I Minkov
Journal:  Cell Mol Life Sci       Date:  2002-04       Impact factor: 9.261

Review 9.  Protective and pathogenic functions of macrophage subsets.

Authors:  Peter J Murray; Thomas A Wynn
Journal:  Nat Rev Immunol       Date:  2011-10-14       Impact factor: 53.106

Review 10.  Oxidative stress in normal and impaired wound repair.

Authors:  Matthias Schäfer; Sabine Werner
Journal:  Pharmacol Res       Date:  2008-06-19       Impact factor: 7.658

View more
  3 in total

1.  The One That Got Away: How Macrophage-Derived IL-1β Escapes the Mycolactone-Dependent Sec61 Blockade in Buruli Ulcer.

Authors:  Belinda S Hall; Louise Tzung-Harn Hsieh; Sandra Sacre; Rachel E Simmonds
Journal:  Front Immunol       Date:  2022-01-26       Impact factor: 7.561

2.  Genome-wide screening identified SEC61A1 as an essential factor for mycolactone-dependent apoptosis in human premonocytic THP-1 cells.

Authors:  Akira Kawashima; Mitsuo Kiriya; Junichiro En; Kazunari Tanigawa; Yasuhiro Nakamura; Yoko Fujiwara; Yuqian Luo; Keiji Maruyama; Shigekazu Watanabe; Masamichi Goto; Koichi Suzuki
Journal:  PLoS Negl Trop Dis       Date:  2022-08-08

Review 3.  Protective Efficacy of BCG Vaccine against Mycobacterium leprae and Non-Tuberculous Mycobacterial Infections.

Authors:  Davit Orujyan; William Narinyan; Subhapradha Rangarajan; Patrida Rangchaikul; Chaya Prasad; Beatrice Saviola; Vishwanath Venketaraman
Journal:  Vaccines (Basel)       Date:  2022-03-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.